with 10% FBS and maintained at 37℃ in a humidified 5% CO 2 atmosphere. The 1 3 4 viabilities of the HCs and HSCs were assessed by trypan blue exclusion and the purity 1 3 5 were tested using glial fibrillary acidic protein (GFAP) (quiescent HSC marker; 1:100; 1 3 6 16825-1-AP, Proteintech Group, China), Acta2 (activated HSC marker; 1/100; ab7817; 1 3 7
Abcam, Cambridge, UK) and cytokeratin 18 (HC marker; 1:100; 10830-1-AP, 1 3 8 Proteintech Group) ( Supplementary Fig. 1 ). To further confirm the effects of LXRs 1 3 9
and Hh signaling on HSC activation, after 3 days of isolation, primary HSCs were Cells or liver samples were lysed in radioimmunoprecipitation assay buffer with 1 7 2 protease inhibitors, and the concentration of the resulting protein extract was 1 7 3 measured using the bicinchoninic acid assay. The extracted proteins were separated 1 7 4 by SDS-PAGE (10% gel) and transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% non-fat milk and immunological detection was 1 7 6 performed with the following primary antibodies: Acta2 (1:1,000), collagen I (1:500; 1 7 7 14695-1-AP; Proteintech, Rosemont, IL, USA), LXRα (1:1,000), LXRβ (1:1000), 1 7 8 sterol regulatory element binding protein-1c (Srebp1-c; 1:1000; ab28481; Abcam), 1 7 9 ATP binding cassette subfamily A member 1 (Abca1; 1:500, Ag24118; Proteintech), 1 8 0 Patched (Ptch; 1:1,000; PA5-18544, RRID AB_10983895; Thermo Fisher Scientific, 1 8 1 Inc.) and sonic hedgehog homolog (Shh; 1:500, 20697-1-AP; Proteintech) overnight 1 8 2 at 4℃, followed by incubation with a peroxidase-coupled secondary antibody for 1 h 1 8 3 at 37℃. The blots were visualized using an enhanced chemiluminescence kit 1 8 4 (Amersham, UK). Total RNA was extracted from the cells or tissue samples using the RNeasy Mini 1 8 8
Kit (Qiagen, Valencia, CA), following the manufacturer's instructions. Equal amounts 1 8 9 of total RNA from each sample was prepared and reverse transcribed into 1 9 0 complementary DNA. Supplementary Table 1 lists the specific oligonucleotide 1 9 1 primers used. The PCR thermocycling conditions were as follows: 95℃ for 30 s 1 9 2 followed by 39 cycles of 95℃ for 5 s and 56℃ for 30 s using SyBr Green reagents 1 9 3 (Biosystems, Foster City, CA). The gene expression was calculated using the 2 Δ Δ Ct 1 9 4 method and normalized to the housekeeping gene GAPDH. 1 9 5 1 9 6 6. Statistical analysis 1 9 7
All data were analyzed using SPSS version 19.0 software. Quantitative data are 1 9 8 expressed as the mean ± standard deviation of at least 5 independent experiments for 1 9 9 animal studies, and at least 3 independent experiments for each cell experimental 2 0 0 group. The groups were analyzed using Student's t-test and P<0.05 was considered to 2 0 1 indicate statistically significant differences. Therefore, in order to identify the underlying mechanisms of HSC activation, we 2 0 7 tested gene expression in freshly isolated HSCs from healthy mice for 168 h. The 2 0 8 freshly isolated quiescent HSCs had a round, phase-dense cell appearance with large 2 0 9 numbers of refractile lipid droplets, which appeared garland-like by Oil red O staining. 2 1 0
The purity of the HSCs was approximatively 90%, as determined by quiescent HSC 2 1 1 marker GFAP and activated HSC marker Acta2 (Fig. 1A) . Notably, collagen I and 2 1 2 Acta2, regarded as specific markers of HSC activation, exhibited a marked 2 1 3 upregulation during in vitro HSC culture ( Fig. 1B) . LXRα and LXRβ, and their target 2 1 4 genes Srebp1 and Abca1 significantly decreased during HSC activation (Fig. 1C ). The 2 1 5 protein levels of the indicators of HSC activation, LXRs and their target genes were 2 1 6 further confirmed by western blotting. The observed trend for each protein was 2 1 7 consistent with the corresponding mRNA expression ( Fig. 1D ). The results confirm 2 1 8 that both of LXRα and LXRβ may play roles in HSCs activation. According to previous studies, primary isolated HSCs are activated and induce 2 2 2 high levels of activation markers Acta2 and collagen I in vitro following 72 h of 2 2 3 culture [21] . Therefore, in the present study, freshly isolated HSCs were tested 2 2 4 following culture for 72 h. Firstly, an LXR agonist and antagonist were tested to 2 2 5 confirm the regulatory effect of LXRs on the activation of mouse primary HSCs. As 2 2 6 expected, LXR agonist T0901317 led to a significant increase in the mRNA levels of 2 2 7 Abca1 and Srebp1, and suppressed the activation of the mouse primary HSCs. In 2 2 8 addition, LXR antagonist SR9238 decreased the expression of LXR target genes and 2 2 9 notably promoted the activation of HSCs (P<0.05; Fig. 2A ). Subsequently, the 2 3 0 endogenous expression levels of LXRα and LXRβ were measured in mice primary 2 3 1 HCs and HSCs, and normalized to the levels of the housekeeping gene GAPDH. LXRα was mainly expressed in HCs, while, HSCs expressed high levels of LXRβ 2 3 3 (P<0.01; Fig. 2B ). Similarly, freshly isolated HSCs exhibited strong nuclear 2 3 4 expression of LXRβ, but almost undetectable levels of LXRα after culture for 24 h 2 3 5 (Fig. 2C ). Furthermore, we determined the effect of the knockdown of each LXR 2 3 6 isoform on the expression of major LXR target genes and the activation of HSCs. After 72 h of culture, siRNA was used to silence LXRα or LXRβ in mouse primary 2 3 8
HSCs. The cells in the control group were transfected with siRNA containing a 2 3 9 scrambled sequence. Despite efficient silencing, no obvious effect by the LXRα 2 4 0 knockdown was observed on Abca1 or Srebp1 on the transcription level, and no 2 4 1 significant activation of HSCs was noted (P>0.05). In contrast, LXRβ silencing led to 2 4 2 a notable decrease in the expression levels of LXR target genes, and promoted HSCs 2 4 3 activation, as measured by Acta2 and collagen I mRNA expression (P<0.05; Fig. 2D ). The impact of LXRα and LXRβ silencing was also investigated at the protein level. Compared with the mRNA results, similar changes in the protein levels were observed 2 4 6 by western blot analysis ( Fig. 2E ). Additionally, HSCs in the LXRβ-silenced group 2 4 7 exhibited a high expression of Acta2 and displayed more fibrocyte morphological 2 4 8 0 T0901317-treated group displayed a significant increase in Abca1 and Srebp1 levels, 2 7 1 compared with the control groups (control vehicle and Ad-control-CCl 4 ). However, 2 7 2 overexpression of LXRβ in the mice resulted in just a moderate increase of the 2 7 3 expression of Abca1 and Srebp1, suggesting that activation of LXRβ does not 2 7 4 significantly impact the lipid metabolism in the liver (Fig. 3C ). Acta2 staining was 2 7 5 performed to observe the infiltration of activated HSCs in the liver following chronic 2 7 6 injury. The population of Acta2 + cells was greatly increased in the 2 7 7
Ad-control-CCl 4 -treated mice compared with those in the mice treated with the 2 7 8 control vehicle, indicating that chronic liver injury can produce significant HSC 2 7 9 activation (P<0.01; Fig. 3B and E) . Conversely, the number of Acta2 + cells was 2 8 0 markedly lower in the LXRβ-overexpressed mice compared with that in the 2 8 1 Ad-control-CCl 4 -treated mice (P<0.05; Fig. 3B and D) . These data suggest that LXRβ 2 8 2 suppresses the process of HSC activation and inhibits fibrogenesis in a fibrosis mouse 2 8 3 model without resulting in liver steatosis. 
LXRβ may inhibit HSC activation in vivo via Hh signaling 2 8 6
Hh signaling is crucial in developmental pattern formation, and stem cell growth 2 8 7 and maintenance [22] . This signaling pathway is dormant in the livers of healthy 2 8 8 adults, and is activated during liver injury, which triggers the production of Hh 2 8 9 ligands and the expression of Hh target genes. It has been reported that Hh signaling 2 9 0 is important for HSC activation and liver fibrogenesis [23, 24] . As Hh signaling is 2 9 1 negatively regulated by LXR [25, 26] , we hypothesized that the role of LXRβ in the 2 9 2 regulation of HSC activation and fibrogenesis is exerted via Hh signaling. In order to 2 9 3 test this hypothesis, the Hh pathway activity was investigated in CCl 4 -induced liver 2 9 4 injury. Double immunofluorescence for Acta2 and Gli2, a main Hh target gene, was 2 9 5 performed to assess Hh signaling in activated HSCs. Fig. 4A demonstrates the nuclear 2 9 6
Gli2 localization in activated, Acta2 + HSCs in the livers of CCl 4 -treated mice, and the 2 9 7 low expression in the healthy livers of the control vehicle group. Notably, the livers 2 9 8 from the Ad-control-CCl 4 -treated group exhibited markedly increased Gli2 nuclear 2 9 9 staining in myofibroblastic cells located in the fibrotic areas (4.6-fold increase vs. 3 0 0 control). However, the overexpression of LXRβ significantly suppressed the number 3 0 1 of Acta2 + cells as well as the nuclear expression of Gli2 (P<0.01; Fig. 4A and B) . To further support the aforementioned hypothesis, mouse primary HSCs were isolated 3 1 7 and cultured for 168 h. We found that the HSC activation process was accompanied 3 1 8 by the activation of Hh signaling. Ptch and Gli2 were almost undetectable in freshly 3 1 9 isolated, quiescent HSCs, but significantly upregulated during HSC activation 3 2 0 (P<0.01; Fig. 5A and B ). An Hh agonist and antagonist were then used to test the role 3 2 1 of Hh signaling in the activation of HSCs. Accordingly, the mRNA expression levels 3 2 2 of collagen I and Acta2 were upregulated by approximately 3.3-and 2.1-fold, 3 2 3 respectively, following treatment with Hh agonist Purmorphamine compared with 3 2 4 vehicle (P<0.01; Fig. 5C ). In contrast, following treatment with Hh antagonist 3 2 5 GDC0449, the levels of collagen I and Acta2 mRNA decreased by approximately 51 3 2 6 and 53%, respectively (P<0.05; Fig. 5C ). These data demonstrate that Hh signaling is 3 2 7 essential for HSC activation and fibrosis. To further confirm that Hh signaling 3 2 8 controls HSC activation and is mediated by LXRβ, we transfected siRNA targeting 3 2 9 LXRα or LXRβ, or adenovirus-mediated vectors overexpressing LXRα or LXRβ into 3 3 0
HSCs, and observed their effects on Hh signaling. Silencing LXRβ in HSCs led to a 3 3 1 marked upregulation of Hh target genes Gli2 and Ptch, and HSC activation markers 3 3 2 collagen I and Acta2. Additionally, we observed that overexpression of LXRβ 3 3 3 decreased the expression of Gli2 and Ptch in HSCs, and suppressed their activation, as 3 3 4 measured by collagen I and Acta2 protein levels (P<0.05; Fig. 5D ). Conversely, in the 3 3 5
LXRα overexpression or knockdown groups, no significant differences were observed 3 3 6 in the expression of Hh target genes or the levels of the HSC activation marker 3 3 7 proteins, compared with the control group (P>0.05; Fig. 5D ). This supports the 3 3 8 conclusion that LXRβ is the main LXR isoform regulating HSC activation. shown in Fig. 5F , purmorphamine significantly induced the protein expression of Hh 3 4 9 target genes Ptch and Gli2, and upregulated HSC activation markers collagen I and 3 5 0 Acta2 in HSCs. Overexpression of LXRβ did not block purmorphamine-stimulated 3 5 1 induction of Ptch and Gli2 but partially inhibited the upregulation of HSC activation 3 5 2 markers. In contrast, GDC0449 significantly inhibited the protein levels of Ptch, Gli2, 3 5 3 collagen I and Acta2 in HSCs, while silencing LXRβ partially rescued the inhibiting 3 5 4 effects of GDC0449. Thus, Hh signaling is only a part of complex mechanisms for 3 5 5
LXRβ-influenced HSC activation. Additionally, Hh ligands Shh was drastically 3 5 6 upregulated by purmorphamine treatment, but completely abolished while 3 5 7 overexpression of LXRβ in HSCs, indicating that LXRβ influences the Hh signaling 3 5 8
